The Prostate

Cover image for Vol. 71 Issue 3

15 February 2011

Volume 71, Issue 3

Pages 225–331

  1. Original Articles

    1. Top of page
    2. Original Articles
    1. Evidence for an association between prostate cancer and chromosome 8q24 and 10q11 genetic variants in African American men: The flint men's health study (pages 225–231)

      Yunfei Wang, Anna M. Ray, Emilie K. Johnson, Kimberly A. Zuhlke, Kathleen A. Cooney and Ethan M. Lange

      Version of Record online: 17 AUG 2010 | DOI: 10.1002/pros.21234

    2. Inhibition of ADAM9 expression induces epithelial phenotypic alterations and sensitizes human prostate cancer cells to radiation and chemotherapy (pages 232–240)

      Sajni Josson, Cynthia S. Anderson, Shian-Ying Sung, Peter A.S. Johnstone, Hiroyuki Kubo, Chia-Ling Hsieh, Rebecca Arnold, Murali Gururajan, Clayton Yates and Leland W.K. Chung

      Version of Record online: 29 JUL 2010 | DOI: 10.1002/pros.21237

    3. Inhibition of androgen receptor functions by gelsolin FxxFF peptide delivered by transfection, cell-penetrating peptides, and lentiviral infection (pages 241–253)

      Dennis J. van de Wijngaart, Hendrikus J. Dubbink, Michel Molier, Carola de Vos, Guido Jenster and Jan Trapman

      Version of Record online: 5 AUG 2010 | DOI: 10.1002/pros.21238

    4. Prominin-1 (CD133) is not restricted to stem cells located in the basal compartment of murine and human prostate (pages 254–267)

      Ewa Missol-Kolka, Jana Karbanová, Peggy Janich, Michael Haase, Christine A. Fargeas, Wieland B. Huttner and Denis Corbeil

      Version of Record online: 17 AUG 2010 | DOI: 10.1002/pros.21239

    5. Targeting prostate cancer angiogenesis through metastasis-associated protein 1 (MTA1) (pages 268–280)

      Li Kai, Jun Wang, Marina Ivanovic, Yeon-Tae Chung, William B. Laskin, Frank Schulze-Hoepfner, Yelena Mirochnik, Robert L. Satcher Jr. and Anait S. Levenson

      Version of Record online: 17 AUG 2010 | DOI: 10.1002/pros.21240

    6. High level PSMA expression is associated with early psa recurrence in surgically treated prostate cancer (pages 281–288)

      Sarah Minner, Corinna Wittmer, Markus Graefen, Georg Salomon, Thomas Steuber, Alexander Haese, Hartwig Huland, Carsten Bokemeyer, Emre Yekebas, Judith Dierlamm, Stefan Balabanov, Ergin Kilic, Waldemar Wilczak, Ronald Simon, Guido Sauter and Thorsten Schlomm

      Version of Record online: 31 AUG 2010 | DOI: 10.1002/pros.21241

    7. Long-Term corticosterone treatment induced lobe-specific pathology in mouse prostate (pages 289–297)

      Ulla Simanainen, Anita Lampinen, Holger Henneicke, Tara C. Brennan, Uta Heinevetter, D. Tim Harwood, Keely McNamara, Markus Herrmann, Markus J. Seibel, David J. Handelsman and Hong Zhou

      Version of Record online: 17 AUG 2010 | DOI: 10.1002/pros.21242

    8. Statins reduce the androgen sensitivity and cell proliferation by decreasing the androgen receptor protein in prostate cancer cells (pages 298–304)

      Akira Yokomizo, Masaki Shiota, Eiji Kashiwagi, Kentaro Kuroiwa, Katsunori Tatsugami, Junichi Inokuchi, Ario Takeuchi and Seiji Naito

      Version of Record online: 17 AUG 2010 | DOI: 10.1002/pros.21243

    9. You have full text access to this OnlineOpen article
      Expression of pleiotrophin in the prostate is androgen regulated and it functions as an autocrine regulator of mesenchyme and cancer associated fibroblasts and as a paracrine regulator of epithelia (pages 305–317)

      Brigid Orr, Griet Vanpoucke, O. Cathal Grace, Lee Smith, Richard A. Anderson, Antony C.P. Riddick, Omar E. Franco, Simon W. Hayward and Axel A. Thomson

      Version of Record online: 1 SEP 2010 | DOI: 10.1002/pros.21244

    10. Epigenetic silencing of SOCS3 identifies a subset of prostate cancer with an aggressive behavior (pages 318–325)

      Francesco Pierconti, Maurizio Martini, Francesco Pinto, Tonia Cenci, Sara Capodimonti, Alessandro Calarco, Pier Francesco Bassi and Luigi Maria Larocca

      Version of Record online: 17 AUG 2010 | DOI: 10.1002/pros.21245

    11. Serum miRNA-21: Elevated levels in patients with metastatic hormone-refractory prostate cancer and potential predictive factor for the efficacy of docetaxel-based chemotherapy (pages 326–331)

      Hai-Liang Zhang, Li-Feng Yang, Yao Zhu, Xu-Dong Yao, Shi-Lin Zhang, Bo Dai, Yi-Ping Zhu, Yi-Jun Shen, Guo-Hai Shi and Ding-Wei Ye

      Version of Record online: 14 SEP 2010 | DOI: 10.1002/pros.21246